Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy - Join Clinical Trial NCTNCT06680596
How to Join This Clinical Trial - NCTNCT06680596
Learn how to participate in this PHASE2 trial studying an investigational therapy for Breast Cancer Metastatic, Breast Cancer Stage IV. Current status: NOT_YET_RECRUITING.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Breast Cancer Metastatic, Breast Cancer Stage IV. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Breast Cancer Metastatic, Breast Cancer Stage IV
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE2 - Safety and effectiveness study
- Enrollment Status
- NOT_YET_RECRUITING
- Study Identifier
- NCTNCT06680596 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 34 locations. Find a study site near you:
Clinical Research Site
Amiens, 80054 - France
Status: Contact for availability
Clinical Research Site
Amiens, 80090 - France
Status: Contact for availability
Clinical Research Site
Auxerre, 89000 - France
Status: Contact for availability
Clinical Research Site
Avignon, 84918 - France
Status: Contact for availability
Clinical Research Site
Bayonne, 64100 - France
Status: Contact for availability
Clinical Research Site
Beauvais, 60021 - France
Status: Contact for availability
Clinical Research Site
Blois, 41000 - France
Status: Contact for availability
Clinical Research Site
Brest, 29200 - France
Status: Contact for availability
Clinical Research Site
Brest, 29200 - France
Status: Contact for availability
Clinical Research Site
Chalon-sur-Saône, 71100 - France
Status: Contact for availability
And 24 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE2 clinical trial for Breast Cancer Metastatic, Breast Cancer Stage IV:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships